Functional evidence, measured over time

Meet MyoReactor™

A research-use platform that cultures, stimulates, and repeatedly measures force in living engineered skeletal muscle—so one tissue can reveal maturation, response, injury, washout, and recovery.

DirectInline force sensing
RepeatedSame living tissue
IntegratedCulture through analysis
The missing endpoint

Cell survival is not muscle performance.

Viability, imaging, molecular markers, and terminal measurements each tell part of the story. Drug developers and researchers also need to know whether organized muscle can generate, sustain, and recover force—and how that function changes over time.

Conventional snapshots

  • Separate tissues at each time point
  • Proxy or destructive endpoints
  • Limited view of onset and recovery

The MyoReactor approach

  • Each tissue establishes its own baseline
  • Direct passive, twitch, tetanic, and fatigue outputs
  • Longitudinal response, washout, and recovery trajectories
Integrated platform

Built around living muscle function.

MyoReactor combines the physical environment, stimulation, measurement, and analysis required to move from engineered tissue to decision-relevant functional data.

01

Controlled culture

A compact environmental control unit supports long-duration engineered-muscle maintenance.

02

Standardized chamber

A sterilizable chamber integrates tissue attachment, a fixed anchor, controlled media access, and sensor alignment.

03

Programmable stimulation

Integrated electrodes evoke reproducible twitch, tetanic, fatigue, and recovery responses.

04

Inline force sensing

Direct measurements are collected without transferring the tissue to a separate force bath.

05

Longitudinal design

The same construct is followed across maturation, exposure, injury, washout, and recovery.

06

Analysis software

Raw traces become passive tension, twitch, tetanic force, kinetics, fatigue, and recovery outputs.

One continuous experiment

From baseline to recovery.

A function-first workflow helps resolve not only whether an intervention changes muscle, but when the change begins, how it progresses, and whether the tissue recovers.

Fabricate

Form living 3D engineered muscle.

Mature

Maintain tissue under controlled conditions.

Baseline

Qualify each construct’s starting function.

Intervene

Apply a drug, toxicant, stressor, or genetic model.

Track

Measure progression, washout, and recovery.

Applications

Functional answers for muscle-focused decisions.

The initial commercial focus is research-use testing for pharmaceutical, biotechnology, CRO, toxicology, academic, and government teams.

Rx

Drug efficacy

Compare magnitude, onset, durability, fatigue response, and functional rescue.

Tx

Myotoxicity

Detect functional impairment that may precede overt cell death or visible damage.

DNA

Genetic models

Measure deficits and rescue across disease-associated or loss-of-function muscle models.

NMJ

Neuromuscular research

Support future studies of muscle–nerve interaction and functional response.

Δt

Aging, disuse & recovery

Resolve adaptation and recovery during long-duration physiological studies.

NAM

Human-relevant testing

Triage candidates and doses and refine later studies within validated contexts of use.

Development program

Advancing from prototype to beta-ready system.

SOMA’s program is designed to establish analytical performance, biological utility, model versatility, and a transferable external-user workflow.

AIM 1

Analytical performance

Establish sensitivity, accuracy, linearity, repeatability, inter-device reproducibility, temporal response, hysteresis, and drift.

AIM 2

Biological utility

Test an acute contraction enhancer, reversible inhibitor, and progressive myotoxicant against orthogonal endpoints.

AIM 3

Platform versatility

Demonstrate performance across human cell sources, iPSC or immortalized cells, and genetically altered muscle models.

SOMA team

Muscle biology meets product engineering.

The team combines decades of engineered-muscle physiology with hands-on development of the MyoReactor’s tissue, mechanical, and operational workflows.

Lisa M. Larkin, PhD

Lisa M. Larkin, PhD

CEO / CSO / Founder & Inventor

Scientific direction, muscle physiology, intellectual property, partnerships, and platform roadmap.

Eileen Su

Eileen Su

PD / PI & Program Leader

Program execution, integration, milestones, risk management, and product development.

Derek Hwang

Derek Hwang

Product Development Engineer

Mechanical design, chamber refinement, sensor alignment, calibration, and design for manufacture.

Measure what living muscle can do—not only what it contains.

MyoReactor is being developed to bring direct, longitudinal functional evidence into human engineered-muscle research.

Research-use platform in developmentNot intended for clinical diagnosis or treatment. Application-specific evidence will define appropriate contexts of use.